戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 r titin (TTN) are the leading known cause of familial dilated cardiomyopathy.
2 iciency is probably the most common cause of familial dilated cardiomyopathy.
3  2 different SCN5A mutations associated with familial dilated cardiomyopathy.
4 ), which has previously been associated with familial dilated cardiomyopathy.
5 proteins have been recorded in patients with familial dilated cardiomyopathy.
6 aluations were performed in 21 kindreds with familial dilated cardiomyopathy.
7 lioma, split-hand/foot deformity type 1, and familial dilated cardiomyopathy.
8 udied in wild-type mice and a mouse model of familial dilated cardiomyopathy.
9 study is to identify novel mutations causing familial dilated cardiomyopathy.
10 e, familial hypertrophic cardiomyopathy, and familial dilated cardiomyopathy.
11 unt for approximately 10 percent of cases of familial dilated cardiomyopathy and are particularly pre
12 lament-Ca(2)(+) responsiveness in a model of familial dilated cardiomyopathy and improve cardiac func
13 AG3 are associated with an increased risk of familial dilated cardiomyopathy, and common variants are
14                                Some cases of familial dilated cardiomyopathy are caused by mutations
15 C (LMNA) gene mutations are a known cause of familial dilated cardiomyopathy, but the precise mechani
16                    Although several loci for familial dilated cardiomyopathy (DCM) have been mapped,
17                                              Familial dilated cardiomyopathy (DCM) is a genetically h
18                                              Familial dilated cardiomyopathy (DCM) is a leading cause
19 tif protein 20 (RBM20) are a common cause of familial dilated cardiomyopathy (DCM).
20                                              Familial dilated cardiomyopathy demonstrates incomplete
21 and that two lamin A mutants associated with familial dilated cardiomyopathy, E203G and E203K, exhibi
22 imed to characterize the clinical profile of familial dilated cardiomyopathy (FDC) in the families of
23                Phenotypically, patients with familial dilated cardiomyopathy (FDC) show enlargement o
24 ted cardiomyopathy occurring in families, or familial dilated cardiomyopathy (FDC), may occur in 20%
25 scovery and understanding of the genetics of familial dilated cardiomyopathy (FDC).
26 al rescreening of family members at risk for familial dilated cardiomyopathy (FDC).
27                                              Familial dilated cardiomyopathy (FDCM) and hypertrophic
28 arch comparing the survival of children with familial dilated cardiomyopathy (FDCM) to that of childr
29                                              Familial dilated cardiomyopathy has been shown to be cau
30                                              Familial dilated cardiomyopathy is a genetic cardiomyopa
31                                              Familial dilated cardiomyopathy is an underrecognized fo
32 fy the causal variant in a large family with familial dilated cardiomyopathy of unknown pathogenesis.
33 ecause of prominent genetic heterogeneity in familial dilated cardiomyopathy, recognition of pathogen
34 S for mutations in 116 DCM families from the Familial Dilated Cardiomyopathy Registry and in 309 subj
35 ied, the genetic etiologies of most cases of familial dilated cardiomyopathy remain unknown.
36      Of 4110 women from 520 pedigrees in the Familial Dilated Cardiomyopathy Research Project databas
37      A large family with autosomal dominant, familial dilated cardiomyopathy was identified.
38  pathological remodeling in a mouse model of familial dilated cardiomyopathy with established disease
39 rovided for a novel therapeutic approach for familial dilated cardiomyopathy, with potential applicat